Germline mutations in NBS1, RAD50, and MRE11 genes, although seen in low frequencies and can be population specific, can be qualified as novel candidates for breast cancer susceptibility in a subset of non-BRCA1 and BRCA/2 families. Here, NBN is linked to breast carcinoma.